News + PR
Bushu Pharma will be attending DCAT Week 2022 – being held March 21st – 24th – and is looking forward to reconnecting with colleagues and meeting new ones. For those that are looking to introduce their product portfolios into Japan and the Asian market, we are currently setting up appointments and would welcome the opportunity to discuss your needs and how we can be of potential value through our Gateway to Asia supply chain service and expansion, Feel free to reach out and yes, we look forward to seeing everyone and celebrating the return of DCAT.
It is our pleasure to announce that as part of our expanded partnership with Amgen Group, the first shipment of Amgen products was made from our Kawagoe factory on December 20, 2021. As originally published in our November 9, 2021 press release, the partnership is extremely important to our company, and this shipment is a positive sign that we have successfully taken a major step toward the expansion of our Gateway to Asia service.
As part of our commitment to the environment and to SDGs, more than 70 Bushu Pharma employees recently cleaned the perimeter of our Kawagoe and Misato Plants. Although the activity was limited, we believe that we were able to make a small contribution to maintaining a sustainable living environment for the people living nearby and to preserving the natural environment around our plants.
Amgen and Bushu Pharma Announce An Expanded Supply Chain Management Across Japan and Asia-Pacfific Region
Amgen Inc., Amgen K.K. and Bushu Pharmaceuticals Ltd. (“Bushu Pharma”), Amgen’s contract manufacturing organization (CMO), today announced the expanded Gateway-to-Asia partnership to four countries across the Asia Pacific region.
Bushu Pharmaceuticals Ltd. (hereinafter “Bushu Pharma”) is pleased to announce the opening of the Kazo Packaging Center, which will serve as a new base for the inspection, labeling, packaging, and storage of pharmaceuticals.
As we celebrate #WorldMentalHealthDay on October 10, Bushu Pharma, as a CDMO, has been entrusted with the production of pharmaceuticals for the nervous system and sensory organs, and we pray that these medicines are benefiting patients suffering around the world.
Bushu Pharmaceuticals Ltd. is pleased to announce that Tadao Takano has been appointed President and COO, and Tetsuichi Okada has been appointed Chairman and CEO, effective June 30, 2021.
Bushu Pharma has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company to carry out inspection, labeling, packaging and storage of pharmaceutical products.
Bushu Pharmaceuticals Ltd. has entered into a business alliance agreement with Suzuken Co., Ltd. to offer a service that provides comprehensive support for new product launches for specialty pharmaceutical manufacturers looking to enter the Japanese market.
One of the world’s largest and most trusted providers of business sustainability ratings, EcoVadis – has recently confirmed that Bushu Pharma has met the standards necessary to receive their CSR award medal and certification.